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Abstract
Background: Retail drug shops play a significant role in managing pediatric fevers in rural areas in Uganda.
Targeted interventions to improve drug seller practices require understanding of the retail drug shop market and
motivations that influence practices. This study aimed at describing the operational environment in relation to the
Uganda National Drug Authority guidelines for setup of drug shops; characteristics, and dispensing practices of
private retail drug shops in managing febrile conditions among under-five children in rural western Uganda.
Methods: Cross sectional survey of 74 registered drug shops, observation checklist, and 428 exit interviews using a
semi-structured questionnaire with care-seekers of children under five years of age, who sought care at drug shops
during the survey period. The survey was conducted in Mbarara and Bushenyi districts, South Western Uganda, in
May 2013.
Results: Up to 90 and 79% of surveyed drug shops in Mbarara and Bushenyi, largely operate in premises that meet
National Drug Authority requirements for operational suitability and ensuring medicines safety and quality. Drug shop
attendants had some health or medical related training with 60% in Mbarara and 59% in Bushenyi being nurses or
midwives. The rest were clinical officers, pharmacists. The most commonly stocked medicines at drug shops were
Paracetamol, Quinine, Cough syrup, ORS/Zinc, Amoxicillin syrup, Septrin® syrup, Artemisinin-based combination
therapies, and multivitamins, among others. Decisions on what medicines to stock were influenced by among others:
recommended medicines from Ministry of Health, consumer demand, most profitable medicines, and seasonal disease
patterns. Dispensing decisions were influenced by: prescriptions presented by client, patients’ finances, and patient
preferences, among others. Most drug shops surveyed had clinical guidelines, iCCM guidelines, malaria and diarrhea
treatment algorithms and charts as recommended by the Ministry of Health. Some drug shops offered additional
services such as immunization and sold non-medical goods, as a mechanism for diversification.
Conclusion: Most drug shops premises adhered to the recommended guidelines. Market factors, including client
demand and preferences, pricing and profitability, and seasonality largely influenced dispensing and stocking practices.
Improving retail drug shop practices and quality of services, requires designing and implementing both supply-side
and demand side strategies.
Keywords: Private sector, Retail market, Drug shops, Under-five children, Health care
* Correspondence: cmayora@musph.ac.ug
1School of Public Health, University of Witwatersrand, 27 St. Andrews Road,
Parktown, Johannesburg 2193, South Africa
5Department of Health Policy Planning and Management, Makerere
University School of Public Health, PO Box 7072, Kampala, Uganda
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Mayora et al. BMC Health Services Research  (2018) 18:532 
https://doi.org/10.1186/s12913-018-3343-z
Background
Private retail drug shops play a significant role in health
service delivery in low and middle income countries.
Drug shops are small ‘walk-in’ health care shops that sell
over-the-counter drugs. Sometimes drug shops sell other
products other than medicines. A number of studies
have indicated that in many low and middle income
countries, retail drug shops are critical in providing
health care services, and more so for common childhood
illnesses [1]. In Togo for example, only less than 20% of
under-five sick children visit the health facility, and up
to 83% are managed at home using medicines procured
from the retail market [2]. In Nigeria, more than 60% of
malaria patients obtained their medication through pa-
tent medicine vendors (PMVs) – an equivalent of drug
sellers [3, 4]. In Uganda and Tanzania, a sizeable amount
of antimalarials are accessed through the retail sector
market [5, 6]. Between 40 and 70% of pediatric fevers in
Uganda are managed at retail drug shops, especially in
rural areas. Retail drug shops are utilized as first points
of call for health care for sick children especially in rural
and geographically constrained communities [7–9]. The
evidence on the extent of utilization of private retail
sector by different socioeconomic groups is mixed, and
largely context driven. There are reported variations in
utilization of retail drug shops across and within
countries. However, in urban areas, private retail sector
services were more likely to be utilized by higher socio-
economic groups, compared to rural locations, where
the private retail sector is commonly used by the lower
socioeconomic groups [10].
The prominence of retail drug shops owes itself to
existing constraints in access to public health services,
including: long distances, household poverty, and limited
or even lack of well-functioning public health facilities in
some geographical areas – characterized by inadequate
health workers, drug stock outs, and perceived poor
quality services [6, 9, 11–16]. Retail drug shops are per-
ceived to be accessible, convenient, flexible in terms of
operating hours, offer credit facilities, trusted by com-
munities, and are perceived to provide services at lower
costs [15, 17–19]. However, there are also concerns
about the quality of services retail drug shops provide.
For example, there are reports that most drug shop at-
tendants are unqualified and lack adequate knowledge
and capacity to appropriately identify illnesses and offer
appropriate treatment for illnesses, stocking and dis-
pensing substandard, counterfeit, or even expired drugs,
among others [1, 9, 20].
Notwithstanding the reported challenges, retail drug
shops are a potential way to increase coverage of health
services and achieve universal health coverage (UHC).
Retail providers could relieve pressure off a health care
system that is struggling to deliver comprehensive health
services amidst resource challenges. The Global Fund’s
Affordable Medicines Facility Malaria (AMFm) con-
ducted pilot program in eight countries, including
Uganda, to test the feasibility of subsidizing medicines
through the private sector on availability, affordability
and access to medicines. Results from this AMFm pilot,
indicated that, indeed, subsidizing medicines provided
through the private sector can improve availability, af-
fordability, and access, to medicines particularly for
childhood conditions [21].
In Uganda, drug shops are recognized within the
health care system as part of the private for profit (PFP)
sector. Retail drug shops are registered, licensed and reg-
ulated by the national drug authority (NDA). Drug shops
are classified as ‘C’ (permitted to sell a restricted list of
medicines, including some antimicrobial formulations).
Although drug shops are expected to be registered and
licensed before they start operations [22], this sometimes
is not the case. In addition, while the NDA Act stipu-
lates the type of cadre supposed to run the drug shops,
often times, there is lack of consistent enforcement and
compliance. Sometimes drug shops to present qualified
personnel when seeking for accreditation and thereafter
recruit unqualified ones once licensure processes are
complete. It is therefore not uncommon to find un-
trained staff working in drug shops in addition to stock-
ing medicines that are not recommended for those
classes or drug shops.
While retail drug shops have proliferated in the recent
past especially in low and middle income countries, not
much attention has been paid to them [23]. In Uganda,
studies have focused more on understanding the role of
retail drug shops, quality of services provided, feasibility
of using rapid diagnostics at drug shops, delivering fam-
ily planning products through drug shops, among others
[9, 24–28]. However, in Uganda, there is limited infor-
mation on the structure and operational characteristics
of the retail drug shop market. Yet, this would provide
an important starting point for designing feasible inter-
ventions aimed at improving the potential of retail drug
shops to provide appropriate and quality services. The
aim of this paper was to characterize private retail drug
shops, their operational environment, as well as elicit
factors that influence their day-to-day decisions in the
management of febrile conditions among children less
than five years old in rural South Western Uganda.
Methods
This study used data collected as part of the baseline
survey conducted as part of a research project imple-
mented by Makerere University School of Public Health
(MakSPH), entitled – “ACCESS and EXCESS, EQUITY
and INFORMATION: Point of Care Diagnostics and
Pre-packaged Subsidized Drugs for Integrated Fever
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Management for Malaria, Pneumonia and Diarrhea in
Children at PRIVATE SECTOR Drug Shops in Uganda”
In brief, the research project aimed to test the feasibility
and effect of implementing integrated community case
management (iCCM) for childhood illnesses, on pediatric
care, at licensed retail drug shops in a low malaria trans-
mission setting in Uganda. The baseline survey was con-
ducted in May 2013, among licensed and operational
retail drug shops in two districts of Mbarara and Bushenyi,
in South Western Uganda. More detailed information
about the research project has been published elsewhere
[19, 28]. In the study area, health services are provided
through public health facilities, private-not-for profit facil-
ities, private hospitals and clinics, pharmacies, retail drug
shops, and sometimes the traditional medicine providers.
The districts health system is superintended by the district
health teams (DHT) with the district health officer (DHO)
as the overall technical head. The registration, licensure,
accreditation, and regulation of retail drug shops is the
mandate of the National Drugs Authority (NDA) which
delegates authority to the District Drugs Inspector of each
district (DDI). Among others, applicants intending to
open up drug shops are required to present certificates of
qualification for intending in-charges, letter of commit-
ment from the in-charge, suitability of the premises,
among others [22]. In terms of epidemiology, the preva-
lence of malaria among children (0–59 months) in this re-
gion (South Western Uganda) is reported to be 5.7% (by
Rapid Diagnostic Tests (RDT)) and 4.1% (by Blood Smear
Microscopy (BSM)) which is significantly lower than the
national averages of 30% (by RDT) and 19% (BSM),
among the same group. The same national malaria survey
indicates that malaria prevalence was high in rural areas
(10.1% for Urban versus 32.4% for rural, by RDT, com-
pared with 6.3% for urban versus 22.3% for rural, by BSM)
compared to the urban counterparts [29]. The study area
is a rural setting with socioeconomic and infrastruc-
tural challenges of access to formal health care ser-
vices. Therefore, retail drug shops have emerged to
fill the gap in availability health care facilities within
reach.
Sampling and sample size
A total of 217 drug shops in the study area were
assessed for eligibility. The list was obtained from the
National Drug Authority (NDA) register available at the
District Drug Inspector (DDI). More detail on assessing
the drug shops for inclusion in research project has been
described elsewhere by kitutu et al. [28]. The eligibility
for participation required that drug shops had to be in
the rural area, functional, dealing with human drugs,
and acceptance to participate in the survey. In Mbarara,
out of 152 drug shops, only 61 drug shops met the in-
clusion criteria, but 40 accepted to participate in the
survey. In Bushenyi, 65 drug shops, were eligible, and
data was collected from 34 drug shops. Therefore, a total
of 74 registered, licensed, and functional retail drug
shops were included in this study. During the survey,
drug shop attendants were interviewed. In addition to
the drug shop attendants’ interviews, exit interviews
were conducted with caretakers of children under five
years of age who had come to purchase medicines from
the drug shop during the study period. Taking drug
shops as clusters, and using the Bennet cluster sampling
method [30], 428 exit interviews conducted at 24 clus-
ters were estimated. However, only 12 and 10 clusters in
Mbarara and Bushenyi Districts, respectively, were cov-
ered during the exit interviews. At each selected drug
shop, an average of 20 exit interviews were conducted.
Data collection
Data for this study was collected at baseline (May, 2013)
through a drug shop survey where drug shop attendants
were interviewed using a semi-structured questionnaire
that collected information on drug shop characteristics
and practices: ownership, training of attendants, com-
monly stocked medicines, stocking, prescription and dis-
pensing decisions, among others (see Additional file 1).
Respondents in the exit interviews were caretakers of
children under-five years of age that came to seek care
or to purchase medicines for febrile conditions. These
were contacted immediately as they left the drug shop
and interviewed at a convenient place within the vicinity
of the drug shop, so as not to allow drug seller’s interfer-
ence. The structured exit interview questionnaire
specifically elicited additional information on client char-
acteristics, drug shop diagnostic, prescription, and treat-
ment practices, as well as client decisions around the
drug shop use, nature of illness, onset of illness and time
taken to make a decision to seek care, among others (see
Additional file 2). All data collection tools were trans-
lated into, and interviews conducted in Runyankore, the
local language used in the study area. Research assistants
were selected from the study districts (local area),
because it was necessary to have individuals who spoke
and understood both local language and English. For exit
interviews, interviewers were stationed at locations near
drug shops all through the exit interview period. Exit
interview respondents were recruited consecutively after
they exited the drug shops, and interviewed if they ac-
cepted to participate. Interviewers also observed or
checked the medicines provided to clients to verify the
responses to posed questions.
Analysis and quality control
Research assistants were trained for two days and a pilot
conducted before embarking on full data collection. All
data were checked for completeness and accuracy by the
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group supervisor, at the end of every data collection day.
Data was double-entered in epi data (http://www.epida-
ta.dk) and was analyzed using STATA version 12 (http://
www.stata.com). All data entry, cleaning and transfer
processes were supervised by the lead author for pur-
poses of quality control. This study adopted first level
descriptive analysis, to generate and report results in
terms of means and proportions of variables. Appropri-
ateness of treatment was assessed through exit inter-
views based on reported symptoms and medicines
provided. It is common practice for care-seekers not to
come with sick children to the drug shop, and instead
drug sellers rely on description of symptoms by the care-
giver. Clients were asked at exit, what diagnostic
processes had been conducted, and in some cases what
symptoms had been reported. The interviewers then
checked medicines they had been provided including their
dosages, frequency of use, and other indications. The
reported symptoms and medicines dispensed were then
compared with national and WHO guidelines [31, 32].
Particular variables or characteristics under study were
analyzed and compared across the two study groups
(districts) using a chi-square test, to understand if the
study characteristics differed significantly across the two
study groups. We presented p-values from the corre-
sponding chi-square tests, with a p-value of < 0.05 being
considered statistically significant.
Ethical considerations
This study used data collected through a baseline survey
conducted as part of a research project implemented by
MakSPH whose ethical approval was obtained from the
Uganda National Council for Science and Technology
(UNCST) (#HS1385), and the MakSPH Higher Degrees
Research Ethics Committee (#IRB00011353). In addition,
this particular study was approved by the University of
Witwatersrand Human Research Ethics Committee
(HREC) (#M151016). Further permission was obtained
from the National Drugs Authority (NDA) and the Local
Government authorities for the two districts. Written
consent was obtained from drug sellers and exit clients
who participated in this study.
Results
Characterizing drug sellers and care-seekers of children
under five years of age who use retail drug shops
We profiled the drug shop attendants and the care-
seekers of under-five children who came to seek care
and purchase medicines at the retail drug shop during
the survey period, based on selected socioeconomic indi-
cators, such as training, education status of clients, and
incomes. Results showed that the real owners of drug
shops attended to 26 and 65% of the drug shops sur-
veyed in Mbarara and Bushenyi respectively (Table 1).
Most drug shop surveyed, were attended to by nurses or
midwives, and the rest were nursing assistants, labora-
tory technicians, pharmacists, and clinical officers.
Retail drug shop operational environment and other
services provided
The quality of medicines and other services provided by re-
tail drug shops is partly related to the physical environment
of the drug shops. The National Drug Authority (NDA)
Act recommends that medicine stores should be free from
moisture, direct sunlight, and other exposures. Medicine
storage and exposure to moisture influences the quality and
efficacy of medicines. This study investigated – through in-
terviews and using an observational checklist – the physical
conditions under which retail drug shops operated. In
Table 2, most drug shops adhered to the guidelines speci-
fied in the NDA licensing guidelines. Most surveyed drug
shops had storage area for medicines secured against thefts,
direct sunlight, and moisture, had ceilings and con-
trolled room temperatures, among others, although
additional improvements could be made. Beyond, the
sale and dispensing of medicines, some (12%) retail
drug shops in Bushenyi offered immunization ser-
vices, over two-third of drug shops in both districts
offered Vitamin A supplementation, while others sold
deworming, soft drinks, toiletries, cosmetics products,
mobile telephone credit, among others.
Common signs and symptoms reported at drug shops
Based on results from the exit interviews, the common
signs and symptoms that were reported at drug shops by
care-seekers of children under five years of age, for which
they came to seek medication were: fever (239/428 or
56%), cough (281/428 or 66%), rapid or difficult breathing
(86/428 or 20%), and diarrhea (114/428 or 27%). Other
common childhood illness signs and symptoms reported
at retail drug shops accounted for 101/428 (24%).
Common medicine stocks and stocking decisions
From drug shop attendants’ interviews and observations,
this study found that the common medicines stocked by re-
tail drug shops included Paracetamol, cough syrup, Amoxi-
cillin dry syrup, Quinine, ORS/Zinc, and Artemisinin-based
Combination Therapies (ACTs), among others (Fig. 1).
Drugs shop attendants were asked to elicit the factors they
put under consideration when deciding what medicines to
stock at a particular point in time. The main factors were
reported to be, consideration of Ministry of health recom-
mended drugs (54%), medicines commonly demanded by
clients (70%), most profitable medicines (26%), and seasonal
disease patterns (30%) and the influence of sales agents
from pharmaceutical companies (19%) who sometimes
move around communities and small local towns selling
medicines and other pharmaceutical products.
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Drug shop attendants’ dispensing decisions
Drug sellers’ decisions about what medicines to dis-
pense, were mainly influenced by among others; pre-
scriptions that some clients come with (47%)
(Prescriptions are sometimes provided at public health
facilities), amount of funds that a client comes with at
the drug shop (30%) and client’s patient preferences for
particular medicines (12%), among others (Fig. 2). How-
ever, drugs shop attendants were asked what decisions
they made in cases where clients did not have enough
finances to procure the recommended medicines and dos-
ages, drug sellers reportedly offered additional medicines
on credit (69%), offered cheap alternatives (18%), or re-
ferred the client elsewhere (27%) (Results not shown).
Appropriateness of treatment practices by retail drug
shops
We used exit interviews to understand treatment prac-
tices of drug sellers, particularly the use of appropriate
diagnostics and prescription of medicines. We found
limited use of diagnostics – malaria rapid diagnostic
tests (RDTs), respiratory count timers, and thermome-
ters. Only about 21% care-seekers who brought sick
children reported having been diagnosed with RDTs,
21% with thermometer, and no child had their breathing
rate counted using a respiratory timer. Relating the
symptoms reported by care-seekers and medicines given
at client exit, based on the Uganda iCCM Guidelines
[32], and World Health Organization Guidelines on
rationale medicines use [31], the study found only 4%
had received correct antibiotics, 39% had received anti-
malarials (ACTs), and 57% had received correct diarrhea
treatment. A number of retail drug shops surveyed
however, had clinical guidelines, iCCM guidelines,
malaria and diarrhea treatment algorithms and charts.
Discussion
In this study, we sought to characterize the private retail
drug shops, explore their operational environment, as
well as elicit factors that influence their day-to-day deci-
sions in the management of febrile conditions among
children less than five years old in rural South Western
Table 1 Characterizing drug shop attendants and care-seekers of children under five years seeking care from retail drug shops
Drug seller Characteristics Mbarara (N = 40) Bushenyi (N = 34)
n (%) n (%) P-value*
Who attends to the drug shop
Owner 10 (25.6) 22 (64.7) < 0.00
Highest level of training for drug shop attendant interviewed
Clinical Officer 8 (20.0) 5 (14.7)
Nurse/Midwife 24 (60.0) 20 (58.8) 0.73
Others* 8 (20.0) 9 (26.4)
Monthly salary earnings for drug shop attendants interviewed
USD 9 – USD 44 24 (80.0) 34 (100.0)
USD 45 – USD 88 16 (20.0) 0 (0.00 < 0.00
Care-seekers’ characteristics (Exit interviews) Mbarara (N = 212) Bushenyi (N = 216)
n (%) 95% CI (in %) n (%) 95% CI (in %) P-value*
Highest level of education of care-seeker
University 2 (0.95 [0.2, 3.7] 4 (1.8) [0.69, 4.8]
Tertiary 2 (0.9) [0.2, 3.7] 13 (6.0) [3.51, 10.1]
High School 7 (3.3) [1.5, 6.8] 7 (3.2) [1.54, 6.6]
O-Level 59 (28.1) [22.4, 34.5 76 (35.1) [29.07, 41.8] < 0.00
Primary 123 (58.5) [51.7, 65.0] 109 (50.4) [43.79, 57.1]
None 17 (8.1) [5.0, 12.6] 7 (3.2) [1.54, 6.6]
Employment status of care-seeker (n = 209) (n = 214)
Unemployed 8 (3.8) [1.9, 7.4] 40 (18.6) [13.92, 24.4]
Housewife 25 (11.9) [8.1, 17.0] 53 (24.6) [19.32, 30.8] < 0.00
Self-employed 92 (43.8) [37.2, 50.6] 87 (40.4) [34.07, 47.1]
Civil Servant 5 (2.3) [0.9, 5.6] 5 (2.3) [0.96, 5.4]
Others 80 (38.1) [31.7, 44.8] 29 (13.4) [9.51, 18.7]
*P values presented are derived from chi-square, and it is comparing indicators across the two study groups (districts)
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Table 2 Operational environment and other services provided by retail drug shops
Mbarara District (n = 40) Bushenyi District
(n = 34)
Variables at baseline (n = 74) Number of drug shops (%) Number of drug shops (%) P-value
Drug shop environment/ conditions
There exists a ceiling to control room temperature 40 (100.0) 28 (82.3) < 0.00*
There are windows that can control aeration 29 (72.5) 15 (44.1) < 0.01*
No direct sunlight to area for keeping medicines 40 (100.0) 33 (97.0) 0.27
Medicine store free from moisture from leaks 37 (92.5) 27 (79.4) 0.10
Premises can be secured to prevent theft 38 (95.0) 32 (94.1) 0.86
Other services provided by drug shops
Immunization Services 0 (0.0) 4 (11.7) 0.02*
Vitamin A supplementation 31 (77.5) 23 (67.6) 0.34
Deworming 4 (10.0) 5 (14.7) 0.53
Reporting adverse drug reactions 18 (45.0) 12 (35.2) 0.39
Presence of treatment guidelines
Uganda Clinical Guidelines 16 (40.0) 22 (64.7) 0.03*
iCCM Guidelines 6 (15.00 9 (26.4) 0.22
Malaria treatment algorithms/charts 17 (42.5) 15 (44.1) 0.88
Pneumonia treatment algorithms /charts 2 (5.0) 5 (14.4) 0.15
Diarrhea treatment algorithms/charts 12 (30.0) 15 (44.12 0.20
Other products traded at drug shops
Soft drinks 4 (10.0) 1 (2.9) 0.22
Toiletries 4 (10.0) 2 (5.8) 0.51
Household goods 1 (2.5) 0 (0.0) 0.35
Mobile airtime 3 (7.5) 1 (2.94 0.38
Cosmetics 1 (2.5) 0 (0.0) 0.35
Food items 0 (0.0) 2 (5.8) 0.12
Fig. 1 Commonly stocked medicines by retail drug shops at time of survey. *ACT = Artemisinin-based Combination Therapies, SP=Fansidar,
ORS=Oral Rehydration Solution.
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Uganda. Although the study focused on one segment of
the retail health market – the registered retail drug
shops – the results presented have indeed revealed inter-
esting features of the retail drug shops, which are signifi-
cant for policy and programming. The main findings
indicate that most surveyed retail drug shop premises
met the NDA requirements of setting up premises that
deal in medicines. These guidelines were established to
assure medicines safety and quality. Drug sellers had
health-related qualification with majority being nurses
or midwifes. The most commonly reported and managed
childhood illness signs and symptoms at drug shops
were fever, cough, rapid or difficult breathing, and diar-
rhea. It was also found that retail drug shops commonly
stocked Paracetamol, Quinine, Cough syrup, ORS/Zinc,
Amoxicillin dry syrup, Septrin® syrup, Artemisinin-based
Combination Therapies, and multivitamins. Decisions
on what medicines to stock were influenced by among
others, Ministry of Health recommended medicines,
medicines demand, most profitable medicines, and
seasonal disease patterns. Relatedly, dispensing decisions
were influenced by among others: prescriptions
presented by the client, patients’ finances, and patient
preferences. In response to clients with insufficient re-
sources, drug sellers either offered credit depending on
the relationship and trust cultivated overtime, or offered
cheaper product alternatives.
Our finding that most of drug sellers (attendants) had
health related qualifications – with the common qualifi-
cation being nurses or midwifes, and clinicians, could be
related to the fact that only registered drug shops were
enrolled for the survey, owing to the legal and policy
challenges that would arise by engaging un-registered
and hence unauthorized entities. It is not uncommon
during registration and licensure to ensure drug sellers
with appropriate qualification are responsible, otherwise
a license may never be granted. It is relatively complex
to enforce such requirements for unregistered drug
shops that are essentially operating illegally. It is import-
ant however to note that while the new NDA Profes-
sional Licensing guidelines 2018 [33] allow nurses,
midwives, and Pharmacy Technicians or dispensers to
attend to human drug shops, within the context of
Uganda’s medical training system, nurses and midwives
had no special training that would aid them to prescribe
medicines. For long, it had been Pharmacy Technicians
who were allowed these roles, but with the current
health workforce challenges that characterize Uganda,
manifesting in chronic shortages for human resources
for health, this may not be possible. The training and
skills of drug sellers or attendants has a significant bear-
ing on the quality of services offered at retail drug shops.
Mbonye and colleagues, found professional qualification
of a provider to be highly associated prescriptive
practice, with lower cadre staff (nursing assistants and
enrolled nurses) overprescribed antibiotic [34]. There
are other studies that have reported gaps on training and
skills of drug sellers [35, 36] However, with minimal
complementary training and capacity building support
for example through continuous training, monitoring
and onsite support supervision, drug sellers could im-
prove their treatment and dispensing practices and
hence improve quality of care provided [9, 37, 38].
Our study found that most drug shop premises met
the NDA requirements allowed for premises that operate
drug shops. We found that most surveyed drug shops
had secure drug storage, medicines were protected
against moisture and sunlight, and drug shops operated
under controlled room temperature. Appropriate
conditions for storage and dispensing of medicines are
critical in maintaining their quality and safety during
their shelf life. We found that some drug shops provided
additional services and products beyond medicines, in-
cluding soft drinks, mobile phone credit, deworming,
Fig. 2 Factors influencing drug sellers’ dispensing practices
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and immunization services. For the few drug shops that
provided immunization services, additional storage cap-
acities for vaccines (e.g. refrigeration and cold chain
systems) were not available yet extremely necessary.
However, it is important to note that the current NDA
guidelines and policy framework does not allow retail
drug shops to provide such services. Business diversifica-
tion, the drug sellers argued, was a mechanism for
business sustainability and mitigating high operational
costs. The more diversified the business, the less likely
that a drug shop would rely on one business line as
source of business survival. Product and service diversi-
fication increases retail sales volumes and significantly
reduces the average costs of production, with possibil-
ities of transferring these cost cuttings to clients in form
of reduced prices [39]. Aspects of incentives for business
start-ups and operational costs in retail health markets,
was investigated separately by the author and colleagues,
and findings shall be shared in separate publication. It is
important, however, that these additional lines of busi-
ness are related to the mainstream service or products
being offered. Drug shop operators must also balance
this diversification agenda against its feasibility, risks,
and limitations.
The most common childhood illnesses reported at the
drug shops were found to be fevers, coughs, difficulty in
breathing, and diarrhea. The current burden of child-
hood illnesses in Uganda, shows that malaria, acute re-
spiratory illness and diarrhea are major contributors to
mortality and morbidity for children under five years of
age [29], and this is true for Sub-Saharan Africa (SSA).
To achieve greater reductions in the burden of
under-five mortality and improve child survival in
Uganda, retail drug shops must be brought into perspec-
tive. Retail drug shop practices need to be improved. In
this study, we found limited use of diagnostics – malaria
RDTs, respiratory count timers, and thermometers. As
starting point, there is need to improve diagnostic
capacities of retail drug shops as a critical ingredient for
appropriate treatment and care, and well in line with the
current WHO “test and treat” policy [26, 40, 41].
The potential for drug shops to use RDTs and reduce
the unnecessary prescription and use of antimalarials
has been demonstrated by a number of studies con-
ducted in many settings, including in Uganda [26, 42]
[27, 28, 43]. The WHO “test before treat policy” now rec-
ommends parasitological confirmation of malaria before
antimalarials are provided [44]. Indeed, the WHO
Framework on malaria elimination under the Global
Technical Strategy for Malaria 2016–2030, provides for
creating an enabling environment for ensuring universal
access to malaria prevention, diagnosis, and treatment
[45]. Inappropriate treatment resulting from the limited
application of diagnostics has been a consistent finding
across a number of studies [46–49]. Inappropriate pre-
scription and unnecessary use of antibiotics has been
established to be associated with antimicrobial resistance
(AMR) [50], which is currently a global public health
challenge that must be addressed. The current Malaria
Treatment Policy and the Uganda Malaria Control stra-
tegic Plan now recommend the use of RDTs at commu-
nity level and in the private sector [51], and additional
guidelines for using RDTs in private outlets in Uganda
have been developed [52] . The Global Fund for HIV/
AIDS, Malaria, and Tuberculosis (GFMAT) through the
private sector co-funding mechanism, has also been sup-
porting the private sector in improving the standards of
malaria diagnosis and treatment in Uganda. However,
there are important challenges such as training and
supervision, waste management, streamlining the refer-
ral system from private outlets, surveillance, etc. that
need to be considered [53]. The policy reforms being
undertaken require careful planning and consideration
of training, regulatory, supervisory, and other necessary
capacities, coupled with necessary incentives for private
outlets to improve their practices [26].
Our study found that prescription or dispensing deci-
sions were not only related to existing diagnostic capaci-
ties, but were also influenced by other factors, including:
the clients’ finances, prescriptions that patients came
with, and client’s preferences. Wafula and colleagues, in
a systematic review of drug shops in Sub-Saharan Africa,
reported that, among others, client demand strongly in-
fluenced dispensing practices. They noted that most
drug shops simply sold medicines that clients requested
for or preferred, without necessarily following policy rec-
ommendations. The systematic review also reported
that, rural drug shops provided credit facilities to their
clients, in cases where they had no resources to afford
the full dosages of medicines [54]. Similarly, Goel and
colleagues, in their study of the behavior of retail phar-
macies in developing countries, also reported that client
demand or expectations as well as local regulatory fac-
tors strongly influenced drug selection and dispensing
behavior [55]. Evidence from both our study and the
literature, indicate that dispensing behavior is related to
both demand and supply side factors, and thus, improv-
ing dispensing practices requires strategies or interven-
tions on both the demand side and supply side of the
market. For example, training, monitoring, supervision,
and subsidies (supply side) are critical supply-side strat-
egies. They alone, may not be sufficient in influencing
dispensing behavior, rather, additional demand-side ini-
tiatives are necessary. Programs such as public health
education and the provision of adequate information
through mass media campaigns, may address issues of
adverse effects of incomplete dosages, and the dangers
of self-medication and prescription. Other demand-side
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strategies may include social marketing and the provision
of demand-side subsidies. Demand-side strategies are
aimed at influencing consumer behavior, preferences, and
choices, and this would ultimately influence dispensing
practice [54]. The design of any package of interventions
and market incentives, must however recognize the
broader health system effects that may likely emerge from
those interventions, beyond the market where they are
implemented [19].
Relatedly, drug shop attendants indicated that their
medicine stocking decisions were influenced by: medi-
cines on demand, ministry of health recommended,
most profitable medicines, and seasonal dynamics. These
factors have also been identified in studies elsewhere
[56–58]. According to the NDA Act, drug shops are not
expected to store and dispense antibiotics, except in ex-
ceptional circumstances where a drug shop is allowed to
sell antibiotics especially if the drug shop is the only
sources of such life-saving medicines for particular com-
munities [22]. Our study however, found that amoxicillin
(syrup and capsules) was one of the commonly stocked
and dispensed medicines at surveyed drug shops because
of its high demand. In many cases, drug shops that
stored antibiotics did not display them on the shelf for
fear of reprisals from drug inspectors, but would provide
the client the same on demand. In addition, drug shops
were still found with stocks of medicines such as quinine
that are no longer recommended as first-line treatment
for malaria. Surprisingly, the study found that most drug
shops had clinical guidelines and regulations available,
yet it was clear that many drug sellers were not in many
cases adhering to them. It was not apparently clear
whether it was a deficiency in enforcement, inadequacy
in training, or rather an issue of incentives for adher-
ence. Reflecting on elicited factors that influence treat-
ment practices, private retail drug shops were likely to
promote the practice of self-medication, especially in cir-
cumstances where client preferences, and prescriptions
that come with, were major considerations in dispensing
decisions. Incentive mechanisms that enable drug shops
to adhere to rules could be established, including strong
monitoring and supervision and deregistration in cases
of inappropriate practices [59, 60].
Finally, this study profiled the drug shop clients socio-
economically to get a basic understanding of the type of
clients who procure medicines from the retail drug
shops and the related equity issues. This study found
that care-seekers of children under five years of age who
sought care from retail drug shops during the survey
period were mostly those who are unemployed,
self-employed and less educated. In Uganda, it is not un-
common to find strong relationships between these
strata and lower socioeconomic quintiles. It is important
to note that the poor are also the most vulnerable to the
burden of ill-health. Thus, interventions aimed at
improving retail drug shop practices were likely to bene-
fit the poor in society and ensure improved equity in
access to health care. However to achieve higher equity,
a mix of interventions, including consumer economic
empowerment, and a stronger regulatory regime could
cushion consumers against possible market distortions
and exploitation in the form of high prices and poor
quality of products and services. In addition, there is
need to establish the right incentives that will influence
provider and consumer behavior towards outcomes that
are in public interest [19] [61, 62].
This study however, had some limitations that need to
be underscored, including the fact that only registered
retail drug shops were included in the study. Yet, there
are many unregistered drug shops that partly influence
what happens in that market, and so the results reported
can only be relevant to the extent of registered drug
shops. Unlicensed outlets were excluded from the survey
because it would have been ethically unacceptable to
promote “outlets” that have selected to defy an existing
regulatory regime. Secondly, the determination of appro-
priate treatment was based on responses from
care-seekers during exit interviews. We asked the client
what signs and symptoms they had reported to the drug
seller, observed the medicines that had been provided,
and also compared with clinical guidelines and WHO
guidelines on promoting rational use of medicines, to
generate an “appropriate treatment” outcome. This may
have inherent flaws especially the reliance on signs and
symptoms reported without due diagnosis for conclu-
siveness. We however endeavored to validate the re-
sponse with the drug seller on reported symptoms of
immediate previous client, after the exit interview.
Conclusion
Retail drug shops were an important source of care for
childhood conditions especially in rural and geographic-
ally constrained settings. Most retail drug shops’ physical
environment met the guidelines established by the
National Drugs Authority (NDA). Most Drug shop at-
tendants were nurses, midwifes, clinical officers and
some pharmacists. A physical environment in line with
the NDA guidelines, coupled with some health related
training by drug sellers, offer a starting point to improve
the quality of services retail drug shops provide. Drug
sellers’ stocking and dispensing practices were largely in-
fluenced by market factors including client demand,
client finances, prices and profitability, client prefer-
ences, and seasonal factors. To ensure effectiveness, the
factors influencing drug shop practices and care must be
taken into account for any intervention or strategy.
Mechanisms that influence the market demand and sup-
ply are necessary to improve drug seller practices.
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Strategies such as regulation, monitoring and supervi-
sion, as well empowering communities with information,
and provision of subsidies may be apparent. Additional
support in terms of provision of subsidized medicines
and diagnostic technology may go a long way in redu-
cing prices of medicines and services provided by retail
drug shops, for the ultimate benefit of the consumers.
Beyond subsidization, however, retail drugs shops need
to be, retail drug shops need to be supported through
implementation of capacity building initiatives, such as
periodic trainings of drug sellers to enhance dispensing
capabilities.
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